Administrative prescription review procedures and use of atypical antipsychotic medications in the Department of Veterans Affairs
- PMID: 15224448
- DOI: 10.1023/a:1024491301954
Administrative prescription review procedures and use of atypical antipsychotic medications in the Department of Veterans Affairs
Abstract
Atypical antipsychotic medications vary in cost with limited evidence of differences in effectiveness. Administrative prescription review has been proposed as a way of encouraging use of less expensive medication when there is no specific clinical justification for using more expensive medication. This study examined data from a national GAO survey of 876 veterans affairs (VA) psychiatrists, and national administrative data on the proportion of veterans actually receiving atypical antipsychotic medications. The proportion of psychiatrists in each region reporting that they did not feel free to prescribe expensive drugs when indicated was negatively correlated with the proportion of patients who filled prescriptions for clozapine, the most expensive atypical. The proportion reporting review procedures for prescribing olanzapine was significantly and negatively correlated with the proportion of veterans actually receiving prescriptions for olanzapine and, positively associated with the proportion prescribed risperidone. Nondirective administrative review procedures in VA are significantly associated with actual prescribing patterns and may generate modest cost savings in the prescription of atypical antipsychotic medication.
Similar articles
-
Atypical antipsychotics for psychosis in adolescents.Cochrane Database Syst Rev. 2013 Oct 15;(10):CD009582. doi: 10.1002/14651858.CD009582.pub2. Cochrane Database Syst Rev. 2013. PMID: 24129841 Review.
-
One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia.Curr Med Res Opin. 2008 Dec;24(12):3341-55. doi: 10.1185/03007990802490512. Curr Med Res Opin. 2008. PMID: 18954497 Review.
-
Association of co-morbidities with prescribing patterns and cost savings: olanzapine versus risperidone for schizophrenia.Pharmacoeconomics. 2006;24(12):1233-48. doi: 10.2165/00019053-200624120-00007. Pharmacoeconomics. 2006. PMID: 17129077
-
Benchmarking the quality of schizophrenia pharmacotherapy: a comparison of the Department of Veterans Affairs and the private sector.J Ment Health Policy Econ. 2003 Sep;6(3):113-21. J Ment Health Policy Econ. 2003. PMID: 14646004
-
The effect of institutional fiscal stress on the use of atypical antipsychotic medications in the treatment of schizophrenia.J Nerv Ment Dis. 2001 Jun;189(6):377-83. doi: 10.1097/00005053-200106000-00005. J Nerv Ment Dis. 2001. PMID: 11434638
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical